Headline
The latest stories from AHA Today.
Johnson & Johnson Innovation – JLABS, together with AONL and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL), announced this week that IsoPouch and Pain Rehabilitation Virtual Reality (PR-VR) have been selected as the awardees in the Johnson & Johnson…
To help rural communities address the challenges of delivering quality care via telehealth, especially during emergencies, the National Quality Forum (NQF) announced it convened a committee this week in partnership with the Centers for Medicare & Medicaid Services.
The latest episode of Take 5, a podcast from the Joint Commission, positions diversity and inclusion efforts in the context of patient safety.
The Joint Commission and Joint Commission Resources (JCR), Inc. announced a data transparency initiative this week.
Tuesday, Feb. 2, NOVA Award winners will take part in a webinar at noon ET to share how they identified their community’s needs and developed and implemented their award-winning programs.
The National Institutes of Health (NIH) will collect clinical information on neurological symptoms, complications and outcomes related to COVID-19 through an online data portal created and maintained by NYU Langone Health in New York City.
Data released this week by Eli Lilly showed treatment with a combination of the company’s COVID-19 neutralizing antibodies bamlanivimab and etesevimab reduced the risk of COVID-19 hospitalizations and deaths by 70% among a group of more than 1,000 high-risk patients enrolled in a Phase 3 clinical…
In recent interviews, nurse leaders said collaboration among team members is more important than ever with COVID-19 elevating the risk of burnout.
The COVID-19 pandemic’s continued strain on hospitals has caused high levels of exhaustion and anxiety among health care leaders and staff.
The American Association of Colleges of Nursing (AACN) announced the launch of a national campaign to accelerate the engagement of nursing schools in efforts to vaccinate the public against COVID-19.